French validation of the SAHOT outcome tool after subarachnoid hemorrhage
Official title: Validation of the French Version of the Subarachnoid Haemorrhage Outcome Tool (SAHOT): a Prospective Single-Centre Cohort Study
Run by Fondation Ophtalmologique Adolphe de Rothschild · NCT07894666 · Data updated 2026-11-12
This study tests whether a French version of the SAHOT questionnaire reliably measures outcomes in adults after subarachnoid hemorrhage.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 70 (estimated) |
| Sponsor | Fondation Ophtalmologique Adolphe de Rothschild Research network |
| Locations | 1 site (Paris) |
| Status | Recruiting |
| Started | September 28, 2026 |
| Main results expected | October 1, 2028 |
| Study ends | November 1, 2028 |
| Registry record updated | October 26, 2026 |
| Trial ID | NCT07894666 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults over 18 with a subarachnoid hemorrhage of any cause, assessed within 12 months of the event, seen at the Rothschild hospital, and able to complete the questionnaire (or with a guardian/relative who can participate in proxy form).
✕Probably not a fit
Patients who do not speak French, or who have an active psychiatric disorder that prevents questionnaire completion, may not benefit from this validation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective, single-centre observational study will validate the French translation of the SAHOT, a patient-reported outcome measure for subarachnoid hemorrhage. Adults seen for follow-up within 12 months of SAH will complete the self-administered French SAHOT, with a proxy version available for accompanying relatives. The primary goal is to assess internal consistency of the French SAHOT; seventy participants are planned, with relatives helping complete proxy assessments when appropriate. The study excludes non-French speakers and individuals with psychiatric conditions that preclude questionnaire completion. The Fondation Ophtalmologique Adolphe de Rothschild sponsors the effort, conducted at Hôpital Fondation Adolphe de Rothschild in Paris.
Why it matters
Potential benefit: If successful, the French SAHOT could provide clinicians with a reliable tool to capture cognitive, psychological, physical, and social outcomes after SAH in French-speaking patients.
How similar studies have gone: SAHOT has been developed and validated in English; this is a French-language validation effort to extend its applicability, with prior success in the English-speaking setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria (patients): * Age over 18 years * Subarachnoid haemorrhage of any aetiology * Onset less than 12 months before inclusion * Seen in consultation at the Hôpital Fondation Adolphe de Rothschild * Judged able to complete a self-administered questionnaire by the evaluating clinician * Informed and not opposed to participation (or relative's non-opposition if the patient is under guardianship and/or unable to consent) Inclusion Criteria (relatives): * Age over 18 years * Relative / caregiver of a patient with subarachnoid haemorrhage within the previous 12 months * Attending the follow-up consultation of an included patient * Informed and not opposed to participation Exclusion Criteria (patients and relatives): * Non-French-speaking * Psychiatric disorder judged incompatible with completion of the questionnaires by the investigator
Where it's running
-
Hôpital Fondation Adolphe de Rothschild
Paris, France Recruiting
Study contacts
- Study coordinator: Emma Gentric
- Email: egentric@for.paris
- Phone: +33 1 48 03 65 00
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Smartphone-based EEG to detect hidden awareness in ICU patients with brain injuries
Researchers will test a smartphone-enabled EEG to see if it can reveal Cognitive Motor Dissociation in ICU patients who can’t show commands at bedside.
-
Prognostic model for neurocritical patients using multimodal brain monitoring
This study tests a model that uses EEG, TCD, and NIRS data to predict 90-day outcomes (awake, coma, or death) in adults with acute brain injuries in intensive care.
-
Investigating the effects of stellate ganglion block on retinal blood flow
This study is testing if a special nerve block used for pain relief can improve blood flow in the eyes of patients with severe brain injuries.
-
Evaluating outcomes in neurosurgery using standardized measures
This study is trying to see how different factors affect the results of brain surgeries by collecting information from patients before and after their operations.
-
Assessing ventilatory parameters in patients with acute neurological injuries
This study is trying to see how different breathing machine settings affect the brain health of adults with serious neurological injuries like strokes or brain trauma.
-
Using advanced MRI to study brain metabolism in traumatic brain injury
This study is testing a new type of MRI to see how brain metabolism changes in people with traumatic brain injury compared to healthy individuals and those with a different brain condition.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.